Research Article
Capecitabine Monotherapy as Palliative Treatment for Patients with Recurrent/Metastatic Nasopharyngeal Cancer
Table 4
Treatment-related toxicity of capecitabine.
| | Adverse event | Any grade | Grade I/II | Grade III/IV |
| | Hand-foot syndrome | 14 (27.4) | 11 (21.5) | 3 (5.9) | | Fatigue | 9 (17.6) | 8 (15.7) | 1 (2) | | Diarrhea | 8 (15.6) | 8 (15.6) | | | Nausea/vomiting | 7 (13.7) | 4 (7.8) | 3 (5.9) | | Mucositis | 2 (3.9) | 2 (3.9) | | | Hematological | | | | | Anemia | 5 (9.8) | 5 (9.8) | | Thrombocytopenia | 4 (7.8) | 4 (7.8) | | Neutropenia | 3 (5.8) | 2 (3.9) | 1 (2) | | Elevation of liver transaminases | 2 (3.9) | 1 (2) | 1 (2) |
|
|
Abbreviations: HFS: hand-foot syndrome. Data are presented as numbers (percentages).
|
